ArticleFrontiers in pediatrics2026
Pediatric opioid and cannabis poisoning hospitalizations in the United States, 2016-2022: a national age-matched inpatient analysis.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Pediatric poisonings involving opioids and cannabis represent two evolving public health challenges. This study compared national inpatient outcomes, complications, and hospital charges among children and adolescents hospitalized with a principal diagnosis of opioid vs. cannabis poisoning in the United States. Methods: We conducted a retrospective cohort study using the Healthcare Cost and Utilization Project National Inpatient Sample from 2016 to 2022. Children and adolescents aged 0-18 years with a principal diagnosis of opioid or cannabis poisoning were identified using ICD-10-CM codes. National estimates were generated using the NIS discharge weight (DISCWT), with variance estimation accounting for NIS_STRATUM and HOSP_NIS. A 1:1 nearest-neighbor age-matched analysis was performed on the unweighted discharge records before application of the national weights. Survey-weighted logistic regression was used for binary outcomes, and survey-weighted linear regression was used for length of stay and total hospital charges. Multivariable models were adjusted for age, sex, race Results: The study included 17,555 weighted pediatric hospitalizations, comprising 10,780 opioid-related and 6,775 cannabis-related poisonings. The proportion classified as cannabis poisoning increased from 24.0% in 2016 to 47.2% in 2022 (survey-weighted trend odds ratio per year, 1.18; 95% CI, 1.14-1.23; Conclusion: Cannabis poisoning accounted for an increasing proportion of pediatric opioid and cannabis poisoning hospitalizations during the study period. Nevertheless, opioid poisoning was associated with greater respiratory morbidity, longer hospitalization, and higher hospital charges. These findings support opioid-related respiratory monitoring and harm-reduction efforts by clinicians and public health agencies, together with child-resistant packaging, safe-storage counseling, and caregiver education for cannabis products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.